Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis: a current problem].

Jaime Villalba-Caloca1, María de Lourdes García-García, José Sifuentes-Osornio

  • 1Instituto Nacional de Enfermedades Respiratorias, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, D.F. México.

Gaceta Medica De Mexico
|November 26, 2003
PubMed
Summary

Tuberculosis control faces challenges in Mexico, with high multidrug resistance rates. Understanding immune responses is crucial for developing effective tuberculosis treatments, especially in low-income nations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes in acute pulmonary embolism and their association with adherence to international recommendations around COVID-19 pandemic-induced hospital-strain: The experience in a Mexican tertiary care center.

PloS one·2026
Same author

Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico.

PloS one·2026
Same author

Differentiating proven progressive disseminated histoplasmosis from other diagnoses in hospitalized persons with HIV and suspected progressive disseminated histoplasmosis: Findings from a clinical and demographic study in Mexico.

PLoS neglected tropical diseases·2025
Same author

Granulomatous liver disease in a referral center in Mexico city.

Annals of hepatology·2025
Same author

Molecular characterization of human respiratory syncytial virus in Mexico (season 2023-2024) through whole-genome sequencing.

Scientific reports·2025
Same author

Factors associated with indeterminate QuantiFERON-TB Gold Plus Test results during the COVID-19 pandemic.

PloS one·2025

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Context:

  • Tuberculosis (TB) remains a significant global health issue, with millions of new cases annually.
  • Mexican studies from 1995 highlight difficulties in TB control programs, leading to chronic cases and high multidrug resistance (MDRTB).
  • Mechanisms of protective immunity against Mycobacterium tuberculosis (MTB) in humans are not fully understood.

Purpose:

  • To summarize the challenges in tuberculosis control and multidrug resistance in Mexico.
  • To highlight the role of immune cells in tuberculosis.
  • To discuss strategies for managing multidrug-resistant tuberculosis (MDRTB) in different economic settings.

Summary:

  • Mexican TB control programs in 1995 faced significant hurdles, resulting in accumulated chronic cases and concerning levels of primary and secondary multidrug resistance (23%).

Related Experiment Videos

  • Immune responses involving lymphocyte subpopulations (CD4, CD8) and myeloid cells (macrophages, monocytes) are critical for combating Mycobacterium tuberculosis.
  • While industrialized nations utilize individualized second-line drug treatments for MDRTB based on susceptibility testing, this approach is often unfeasible in low- and middle-income countries.

    • Impact:

    • The findings underscore the need for improved TB control strategies and research into host immunity.
    • The World Health Organization's (WHO) "DOTS plus" initiative offers a standardized regimen approach for MDRTB management, adapted to regional resistance patterns.
    • Addressing drug resistance and understanding immune mechanisms are vital for global tuberculosis eradication efforts.